Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity von von Roemeling, Christina A., Wang, Yifan, Qie, Yaqing, Yuan, Hengfeng, Zhao, Hai, Liu, Xiujie, Yang, Zhaogang, Yang, Mingming, Deng, Weiye, Bruno, Katelyn A., Chan, Charles K., Lee, Andrew S., Rosenfeld, Stephen S., Yun, Kyuson, Johnson, Aaron J., Mitchell, Duane A., Jiang, Wen, Kim, Betty Y. S.

Volltext

Breaking Down the Barriers to Precision Cancer Nanomedicine von von Roemeling, Christina, Jiang, Wen, Chan, Charles K, Weissman, Irving L, Kim, Betty Y.S

Volltext

Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy von Yuan, Hengfeng, Jiang, Wen, von Roemeling, Christina A., Qie, Yaqing, Liu, Xiujie, Chen, Yuanxin, Wang, Yifan, Wharen, Robert E., Yun, Kyuson, Bu, Guojun, Knutson, Keith L., Kim, Betty Y. S.

Volltext

Pathway signature and cellular differentiation in clear cell renal cell carcinoma von Tun, Han W, Marlow, Laura A, von Roemeling, Christina A, Cooper, Simon J, Kreinest, Pamela, Wu, Kevin, Luxon, Bruce A, Sinha, Mala, Anastasiadis, Panos Z, Copland, John A

Volltext

Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes von Qie, Yaqing, Yuan, Hengfeng, von Roemeling, Christina A., Chen, Yuanxin, Liu, Xiujie, Shih, Kevin D., Knight, Joshua A., Tun, Han W., Wharen, Robert E., Jiang, Wen, Kim, Betty Y.S.

Volltext

Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target von von Roemeling, Christina A, Marlow, Laura A, Pinkerton, Anthony B, Crist, Angela, Miller, James, Tun, Han W, Smallridge, Robert C, Copland, John A

Volltext

Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma von VON ROEMELING, Christina A, MARLOW, Laura A, WEI, Johnny J, COOPER, Simon J, CAULFIELD, Thomas R, KEVIN WU, TAN, Winston W, TUN, Han W, COPLAND, John A

Volltext

Neuronal Pentraxin 2 Supports Clear Cell Renal Cell Carcinoma by Activating the AMPA-Selective Glutamate Receptor-4 von VON ROEMELING, Christina A, RADISKY, Derek C, MARLOW, Laura A, COOPER, Simon J, GREBE, Stefan K, ANASTASIADIS, Panagiotis Z, TUN, Han W, COPLAND, John A

Volltext

Designing nanomedicine for immuno-oncology von Jiang, Wen, von Roemeling, Christina A., Chen, Yuanxin, Qie, Yaqing, Liu, Xiujie, Chen, Jianzhu, Kim, Betty Y. S.

Volltext

Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery von Chen, Yuanxin, Liu, Xiujie, Yuan, Hengfeng, Yang, Zhaogang, von Roemeling, Christina A., Qie, Yaqing, Zhao, Hai, Wang, Yifan, Jiang, Wen, Kim, Betty Y. S.

Volltext

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade von von Roemeling, Christina A., Patel, Jeet A., Carpenter, Savannah L., Yegorov, Oleg, Yang, Changlin, Bhatia, Alisha, Doonan, Bently P., Russell, Rylynn, Trivedi, Vrunda S., Klippel, Kelena, Ryu, Daniel H., Grippin, Adam, Futch, Hunter S., Ran, Yong, Hoang-Minh, Lan B., Weidert, Frances L., Golde, Todd E., Mitchell, Duane A.

Volltext

Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases von Von Roemeling, Christina A, Doonan, Bently P, Klippel, Kelena, Schultz, Daniel, Hoang-Minh, Lan, Trivedi, Vrunda, Li, Chenglong, Russell, Rylynn A, Kanumuri, Raju S, Sharma, Abhisheak, Tun, Han W, Mitchell, Duane A

Volltext

Lessons from immuno-oncology: a new era for cancer nanomedicine? von Jiang, Wen, Yuan, Hengfeng, Chan, Charles K., von Roemeling, Christina A., Yan, Zuoqin, Weissman, Irving L., Kim, Betty Y. S.

Volltext

Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions von Bastea, Ligia I, Liou, Geou-Yarh, Pandey, Veethika, Fleming, Alicia K, von Roemeling, Christina A, Doeppler, Heike, Li, Zhimin, Qiu, Yushi, Edenfield, Brandy, Copland, John A, Tun, Han W, Storz, Peter

Volltext

IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies von Parrondo, Ricardo D., Iqbal, Madiha, Von Roemeling, Reinhard, Von Roemeling, Christina, Tun, Han W.

Volltext

Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy von von Roemeling, Christina A, Caulfield, Thomas R, Marlow, Laura, Bok, Ilah, Wen, Jiang, Miller, James L, Hughes, Robert, Hazlehurst, Lori, Pinkerton, Anthony B, Radisky, Derek C, Tun, Han W, Kim, Yon Son Betty, Lane, Amy L, Copland, John A

Volltext

Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers von Cooper, Simon J, von Roemeling, Christina A, Kang, Kylie H, Marlow, Laura A, Grebe, Stefan K, Menefee, Michael E, Tun, Han W, Colon-Otero, Gerardo, Perez, Edith A, Copland, John A

Volltext

Investigation and modulation of interleukin-6 following subarachnoid hemorrhage: targeting inflammatory activation for cerebral vasospasm von Lucke-Wold, Brandon, Dodd, William, Motwani, Kartik, Hosaka, Koji, Laurent, Dimitri, Martinez, Melanie, Dugan, Victoria, Chalouhi, Nohra, Lucke-Wold, Noelle, Barpujari, Arnav, von Roemeling, Christina, Li, Chenglong, Johnson, Richard D., Hoh, Brian

Volltext

mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors von Trivedi, Vrunda, Yang, Changlin, Klippel, Kelena, Yegorov, Oleg, von Roemeling, Christina, Hoang-Minh, Lan, Fenton, Graeme, Ogando-Rivas, Elizabeth, Castillo, Paul, Moore, Ginger, Long-James, Kaytora, Dyson, Kyle, Doonan, Bently, Flores, Catherine, Mitchell, Duane A

Volltext

Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma von Yushi, Qiu, Li, Zhimin, Von Roemeling, Christina A, Doeppler, Heike, Marlow, Laura A, Kim, Betty Y S, Radisky, Derek C, Storz, Peter, Copland, John A, Tun, Han W

Volltext